Ascendis Pharma AS (ASND):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Ascendis Pharma AS (ASND) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7867
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates for treatment. The company’s products are used in the therapeutic areas of diabetes, growth hormone deficiency, endocrinology, and others. It partners with pharmaceutical and biotechnology companies to develop new products. The company has its operations in the US, Germany and Denmark. Ascendis is headquartered in Hellerup, Denmark.

Ascendis Pharma AS (ASND) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ascendis Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ascendis Pharma A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ascendis Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ascendis Pharma A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Ascendis Pharma A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ascendis Pharma A/S, Medical Equipment, Deal Details 10
Partnerships 10
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 10
Ascendis Pharma Enters Into Collaboration Agreement with Genentech 11
Equity Offering 12
Ascendis Pharma Raises USD258.7 Million in Public Offering of American Depositary Shares 12
Ascendis Pharma Prices Public Offering of American Depositary Shares for USD135 Million 14
Ascendis Pharma A/S – Key Competitors 16
Ascendis Pharma A/S – Key Employees 17
Ascendis Pharma A/S – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 29, 2018: Ascendis pharma announces second quarter 2018 financial results 19
May 30, 2018: Ascendis Pharma Announces First Quarter 2018 Financial Results 20
Mar 28, 2018: Ascendis Pharma Announces Full Year 2017 Financial Results 21
Nov 16, 2017: Ascendis Pharma Reports Third Quarter 2017 Financial Results 22
Aug 18, 2017: Ascendis Pharma Reports Second Quarter 2017 Financial Results 23
May 23, 2017: Ascendis Pharma Reports First Quarter 2017 Financial Results 24
Mar 22, 2017: Ascendis Pharma Reports Full Year 2016 Financial Results 25
Corporate Communications 26
Apr 02, 2018: Ascendis Pharma Appoints Thomas A. Larson as Chief Commercial Officer 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Ascendis Pharma A/S, Medical Equipment, Key Facts, 2017 2
Ascendis Pharma A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ascendis Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ascendis Pharma A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ascendis Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ascendis Pharma A/S, Deals By Market, 2012 to YTD 2018 8
Ascendis Pharma A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 10
Ascendis Pharma Enters Into Collaboration Agreement with Genentech 11
Ascendis Pharma Raises USD258.7 Million in Public Offering of American Depositary Shares 12
Ascendis Pharma Prices Public Offering of American Depositary Shares for USD135 Million 14
Ascendis Pharma A/S, Key Competitors 16
Ascendis Pharma A/S, Key Employees 17
Ascendis Pharma A/S, Subsidiaries 18

List of Figures
Ascendis Pharma A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ascendis Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ascendis Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Ascendis Pharma A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ascendis Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ascendis Pharma A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Ascendis Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ascendis Pharma A/S, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Ascendis Pharma AS (ASND):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ferrellgas Partners, L.P.:企業の戦略・SWOT・財務分析
    Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • NV Energy Inc:企業の戦略的SWOT分析
    NV Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Aspen Pharmacare Holdings Ltd (APN)-製薬・医療分野:企業M&A・提携分析
    Summary Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions. The company also manufactures infant nutritionals and consumer healthcare products in selected territories. Its manufacturi …
  • Distributed Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Distributed Bio Inc (Distributed Bio) is a provider of bioinformatics services. The company offers support of genomic technologies including NextGen sequencing, antibody informatics and computational bioengineering. It provides modern laboratory information management system to manage sequen …
  • Lawson Health Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Lawson Health Research Institute (Lawson) is a hospital-based research institute that offers educational and research programs. The institute’ services include health research programs, medical research programs, educational research programs, scientific research programs, patient care servi …
  • Reliance Communications Limited:企業の戦略・SWOT・財務情報
    Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Detroit Medical Center:企業の戦略的SWOT分析
    Detroit Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Pure Technologies Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Pure Technologies Ltd. (Pure Technologies) develops technologies for inspection, monitoring and management of physical infrastructure such as buildings, water and hydrocarbon pipelines, and bridges. It provides proprietary monitoring equipment for pipelines, bridges and structures; technical …
  • Invion Ltd (IVX)-製薬・医療分野:企業M&A・提携分析
    Summary Invion Ltd (Invion) is a life sciences company that develops products for the treatment of inflammatory diseases such as chronic inflammatory, airway disease and inflammation caused by autoimmune disease. The company's pipeline products include INV102 nadolol, a beta blocker for inflammatory …
  • Wilmar International Limited:企業の戦略・SWOT・財務情報
    Wilmar International Limited - Strategy, SWOT and Corporate Finance Report Summary Wilmar International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kotak Wealth Management:企業の戦略・SWOT・財務分析
    Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sutter Health:企業の戦略的SWOT分析
    Sutter Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • GridPoints Inc:企業の戦略的SWOT分析
    GridPoints Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Verona Pharma Plc (VRP):医療機器:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Strategic Metals Ltd (SMD):企業の財務・戦略的SWOT分析
    Summary Strategic Metals Ltd (Strategic Metals) is a mining and mineral exploration company that acquires, explores, produces, and develops gold properties across Canada. Its portfolio covers a broad suite of metals, including gold, silver, lead, zinc, copper, tin, tungsten, vanadium and lithium. It …
  • Grande Asset Hotels And Property Pcl
    Grande Asset Hotels And Property Pcl - Strategy, SWOT and Corporate Finance Report Summary Grande Asset Hotels And Property Pcl - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Hydro-Electric Corporation:企業の戦略的SWOT分析
    Hydro-Electric Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • China National Petroleum Corporation-石油・ガス分野:企業M&A・提携分析
    Summary China National Petroleum Corporation (CNPC) is an integrated oil and gas company that produces and supplies oil and gas and petrochemical products. The company explores, develops and produces hydrocarbons in onshore and offshore areas of China, Canada, Africa, Central Asia and Russia, Latin …
  • ChargePoint Inc:電力:M&Aディール及び事業提携情報
    Summary ChargePoint Inc (ChargePoint), formerly Coulomb Technologies Inc, is a charging network company that designs, builds and supports electric vehicle charging services. The company provides charging stations for electric vehicles. It designs, builds, and supports charging stations of different …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆